UNSPSC 51263313: Tribendilol

This classification denotes a beta-adrenergic blocking agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K0744Q5ALP. European Medicines Agency schedules Tribendilol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11259MIG. Tribendilol generally arises in the molecular formula C18H22N4O4.

UNSPSC 51263313 Tribendilol is a Commodity code that appears to capture pharmaceutical products, though state and local solicitation activity tagged under this code does not consistently reflect tribendilol procurement specifically. Recent opportunities show state and local governments acquiring naloxone, drug deactivation systems, and direct-to-manufacturer prescription fulfillment capabilities through competitive bidding and market intelligence phases. Issuing bodies include county health departments and state health and human services commissions. The procurement pattern suggests that state and local governments use this code tier for diverse pharmaceutical acquisitions, including emergency-response medications and pharmacy benefit program innovations, rather than a single active pharmaceutical ingredient.

Seminole County, Florida released an IFB (Solicitation IFB60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 drug deactivation systems annually with a response deadline of July 26, 2023 (note: date discrepancy in source), requiring quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with an initial two-year term and one-year renewal option. The Texas Health and Human Services Commission posted an RFI (HHS0017013) on April 3, 2026, to gather vendor capabilities regarding direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and group purchasing organization channels, reflecting early-stage market research rather than formal competitive solicitation. Activity under this code shows geographic spread across Florida and Texas, with issuing bodies spanning county public health and state health commission functions.